Educational only — not medical advice. If you’re in crisis or thinking about suicide: call or text 988 (U.S.) or your local emergency number. Support resources. Under construction and review—see the updates log.
Max 4 meds. Sources include DailyMed labels; verify against official labeling. On small screens the table defaults to a compact view—use “Show all columns” to view everything (scroll horizontally).
Compare 3/4 selected
| Medication | Dosing highlights | Risk flags | LAI options |
|---|---|---|---|
The oral film is placed on the tongue and dissolves without water. Handle with dry hands and place on the tongue immediately after opening the pouch. Designed for observed administration and patients who have difficulty swallowing tablets.
Schizophrenia (adults): recommended dose is 10 to 15 mg once daily, with a maximum of 30 mg/day. No titration is strictly required, though clinical judgment guides starting dose (label). |
| No | |
Schizophrenia (adults): start 10–15 mg once daily; therapeutic range 10–30 mg/day. Doses above 30 mg rarely add benefit. |
| Monthly (q4wk); q4–8wk (varies by strength); Every 2 months (q8wk) | |
Initiation typically follows a “confirm oral tolerability” approach: establish an effective oral dose, administer the first injection, and continue a short oral overlap per label while depot concentrations rise.
Maintenance is usually once monthly; dose selection (e.g., 300 mg vs 400 mg) is individualized to response, tolerability, and interaction profile. |
| Monthly (q4wk) |
2 more columns available — use “Show all columns” above.5 more columns available — use “Show all columns” above.6 more columns available — use “Show all columns” above.